Comparative Evaluation of Antiparkinsonian, Anti-Inflammatory, and Analgesic Effects of Hemantane and Two 2-Aminoadamantane Derivatives Differing From it by a Bridgehead Hydroxyl
- Авторлар: Kapitsa I.G.1, Ivanova E.A.1, Avdyunina N.I.1, Voronina T.A.1
- 
							Мекемелер: 
							- V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
 
- Шығарылым: Том 53, № 5 (2019)
- Беттер: 383-387
- Бөлім: Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
- URL: https://ogarev-online.ru/0091-150X/article/view/245781
- DOI: https://doi.org/10.1007/s11094-019-02009-9
- ID: 245781
Дәйексөз келтіру
Аннотация
2-Adamantylaminopropanol hydrochloride (ADK-971) and 5-hydroxyadamantan-2-ylaminopropanol hydrochloride (ADK-1013) were less active than hemantane in parkinsonian syndrome murine models. ADK-971 and AKD-1013, like hemantane at a dose of 20 mg/kg, exhibited comparable antiexudative effects in the mouse acetic peritonitis model. However, ADK-971 and ADK-1013 (20 mg/kg), in contrast to hemantane at the same dose, did not possess analgesic effects against visceral and thermal somatic pain in mice.
Негізгі сөздер
Авторлар туралы
I. Kapitsa
V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: iwanowaea@yandex.ru
				                					                																			                												                	Ресей, 							Moscow, 125315						
E. Ivanova
V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
							Хат алмасуға жауапты Автор.
							Email: iwanowaea@yandex.ru
				                					                																			                												                	Ресей, 							Moscow, 125315						
N. Avdyunina
V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: iwanowaea@yandex.ru
				                					                																			                												                	Ресей, 							Moscow, 125315						
T. Voronina
V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: iwanowaea@yandex.ru
				                					                																			                												                	Ресей, 							Moscow, 125315						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					